ExploreWatchlistsPricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Cash from investing

AFC-HD AMS Life Science Co.,Ltd. (2927)

Market cap
¥12.5B
P/E ratio
8.2x
AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Aug 31, 2025-3,327+20.48%
Aug 31, 2024-2,761+41.90%
Aug 31, 2023-1,946+80.53%
Aug 31, 2022-1,078+292.02%
Aug 31, 2021-275-40.06%
Aug 31, 2020-459+126.84%
Aug 31, 2019-202-76.21%
Aug 31, 2018-850+0.38%
Aug 31, 2017-847+284.84%
Aug 31, 2016-220+155.04%
Aug 31, 2015-86-66.83%
Aug 31, 2014-260

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat